Texas

Despite the efforts of NACDS, the Texas Federation of Drug Stores (TFDS), the Texas Pharmacy Business Council (TPBC) and other stakeholders to ensure $2.5M in funding for the Texas Board of Pharmacy’s Prescription Monitoring Drug Program’s NarxCare and clinical alerts in SB 8, Rep. John Raney’s (R) amendment we supported was stripped out of the Appropriations bill that passed on the final day of the third special session that ended on Tuesday, October 19^th.

Also in Texas, on November 2^nd, the Board of Pharmacy will convene in-person to consider final adoption of proposed rules that would create two new classes of pharmacy, Class A-N, for community pharmacies compounding certain non-sterile preparations, and Class A-SN designation for community pharmacies compounding both sterile and non-sterile preparations.

Finally in Texas, the Health and Human Services Commission (HHSC) is seeking stakeholder comments on the agency’s funding needs for their 2023 legislative appropriations budget request.  Recommendations must be emailed to CFOStakeholderFeedback@hhs.texas.gov by November 19^th.

For more information, contact NACDS’ Mary Staples at 817-442-1155.